Search results for "serotonin"

showing 10 items of 414 documents

Axonal control of the adult neural stem cell niche.

2014

SummaryThe ventricular-subventricular zone (V-SVZ) is an extensive germinal niche containing neural stem cells (NSCs) in the walls of the lateral ventricles of the adult brain. How the adult brain’s neural activity influences the behavior of adult NSCs remains largely unknown. We show that serotonergic (5HT) axons originating from a small group of neurons in the raphe form an extensive plexus on most of the ventricular walls. Electron microscopy revealed intimate contacts between 5HT axons and NSCs (B1) or ependymal cells (E1) and these cells were labeled by a transsynaptic viral tracer injected into the raphe. B1 cells express the 5HT receptors 2C and 5A. Electrophysiology showed that acti…

Cellular differentiationMessengerRegenerative MedicineMedical and Health SciencesImmunoenzyme TechniquesLateral ventriclesMice0302 clinical medicineNeural Stem CellsReceptor Serotonin 5-HT2C5-HT2CStem Cell NicheNeurons0303 health sciencesMicroscopyBlottingReverse Transcriptase Polymerase Chain ReactionNeurogenesisBrainCell DifferentiationAnatomyBiological SciencesNeural stem cellCell biologySerotonin Receptor AgonistsElectrophysiologyNeurologicalMolecular MedicineStem Cell Research - Nonembryonic - Non-HumanWesternReceptorSerotoninEpendymal CellNeurogenesis1.1 Normal biological development and functioningBlotting WesternBiologySerotonergicReal-Time Polymerase Chain ReactionElectronArticle03 medical and health sciencesUnderpinning researchGeneticsAnimalsRNA Messenger030304 developmental biologyCell ProliferationRapheNeurosciencesCell BiologyStem Cell ResearchAxonsMicroscopy Electronnervous systemRaphe NucleiRNARaphe nuclei030217 neurology & neurosurgeryDevelopmental Biology
researchProduct

Characterization of the transporterB0AT3 (Slc6a17) in the rodent central nervous system.

2013

Abstract Background The vesicular B0AT3 transporter (SLC6A17), one of the members of the SLC6 family, is a transporter for neutral amino acids and is exclusively expressed in brain. Here we provide a comprehensive expression profile of B0AT3 in mouse brain using in situ hybridization and immunohistochemistry. Results We confirmed previous expression data from rat brain and used a novel custom made antibody to obtain detailed co-labelling with several cell type specific markers. B0AT3 was highly expressed in both inhibitory and excitatory neurons. The B0AT3 expression was highly overlapping with those of vesicular glutamate transporter 2 (VGLUT2) and vesicular glutamate transporter 1 (VGLUT1…

Central Nervous SystemMaleSerotonin reuptake inhibitorVesicular glutamate transporter 1Central nervous systemVesicular Transport ProteinsNerve Tissue ProteinsIn situ hybridizationPharmacology and ToxicologyPharmacologyBiologyPlasma Membrane Neurotransmitter Transport ProteinsRats Sprague-DawleyCellular and Molecular NeuroscienceGlutamatergicMiceDopaminePregnancyMonoaminergicmedicineAnimalsRats WistarCells CulturedNeuronsGeneral NeuroscienceNeurosciencesTransporterFarmakologi och toxikologiEmbryo MammalianAntidepressive AgentsRatsMice Inbred C57BLProtein Transportmedicine.anatomical_structureGene Expression Regulationbiology.proteinFemaleFood DeprivationNeurovetenskapermedicine.drugResearch ArticleBMC neuroscience
researchProduct

Serotonin Involvement in the Basal Ganglia Pathophysiology: Could the 5-HT2C Receptor be a New Target for Therapeutic Strategies?.

2006

The basal ganglia are a highly interconnected group of subcortical nuclei in the vertebrate brain that play a critical role not only in the control of movements but also in some cognitive and behavioral functions. Several recent studies have emphasized that serotonergic pathways in the central nervous system (CNS) are intimately involved in the modulation of the basal ganglia and in the pathophysiology of human involuntary movement disorders. These observations are supported by anatomical evidence demonstrating large serotonergic innervation of the basal ganglia. In fact, serotonergic terminals have been reported to make synaptic contacts with dopamine (DA)-containing neurons and gamma-amin…

Central Nervous SystemSerotoninmedicine.medical_specialtySubstantia nigraBiologyIndirect pathway of movementSerotonergicBiochemistrySerotonin AgentsBasal Ganglia DiseasesDopamineInternal medicineSerotonin AgentsDrug DiscoveryBasal gangliaReceptor Serotonin 5-HT2CmedicineAnimalsHumansBasal ganglia diseasegamma-Aminobutyric AcidNeuronsPharmacologyMovement DisordersOrganic ChemistryParkinson Diseasemedicine.diseasebasal ganglion pathophysiology Basal Ganglia Diseases pathophysiologyGlobus pallidusEndocrinologynervous systemSynapsesMolecular Medicinemedicine.drug
researchProduct

Almotriptan: meeting today’s needs in acute migraine treatment

2007

Migraine is a common disorder associated with considerable individual and economic burden. Triptans are recommended for the treatment of migraine of any severity in patients who have failed to gain adequate relief with nonspecific medication; early transition to triptans avoids prolonged morbidity in patients failing to respond to nonspecific medications. There is evidence that early intervention therapy with oral formulations in migraine, soon after the onset of an attack and when pain is still mild, improves efficacy. Seven different triptans are currently marketed, with differing pharmacologic, efficacy and tolerability profiles. Almotriptan has many positive features, which include rigo…

Clinical Trials as Topicmedicine.medical_specialtybusiness.industryMigraine DisordersGeneral NeurosciencePsychological interventionTriptansEarly TherapyPlacebomedicine.diseaseTryptaminesSerotonin Receptor AgonistsSumatriptanTolerabilityMigraineAlmotriptanmedicinePhysical therapyHumansPharmacology (medical)Neurology (clinical)Intensive care medicinebusinessmedicine.drugExpert Review of Neurotherapeutics
researchProduct

Serotoninergic Modulation of Phototactic Variability Underpins a Bet-Hedging Strategy in Drosophila melanogaster

2021

When organisms’ environmental conditions vary unpredictably in time, it can be advantageous for individuals to hedge their phenotypic bets. It has been shown that a bet-hedging strategy possibly underlies the high inter-individual diversity of phototactic choice in Drosophila melanogaster. This study shows that fruit flies from a population living in a boreal and relatively unpredictable climate have more variable variable phototactic biases than fruit flies from a more stable tropical climate, consistent with bet-hedging theory. We experimentally show that phototactic variability of D. melanogaster is regulated by the neurotransmitter serotonin (5-HT), which acts as a suppressor of the var…

Cognitive NeurosciencePopulationZoologyNeurosciences. Biological psychiatry. Neuropsychiatryadaptive strategies ; Drosophila melanogaster ; phototaxis ; serotonin ; variationSerotonergic03 medical and health sciencesBehavioral Neuroscienceadaptive strategies0302 clinical medicineTropical climatePhototaxisMelanogastereducation030304 developmental biologyOriginal Research0303 health scienceseducation.field_of_studybiologyfungibiology.organism_classificationSubarctic climateserotoninNeuropsychology and Physiological PsychologyDrosophila melanogasterphototaxisDrosophila melanogastervariation030217 neurology & neurosurgeryRC321-571Frontiers in Behavioral Neuroscience
researchProduct

Attention-deficit hyperactivity disorder (ADHD), substance use disorders, and criminality: a difficult problem with complex solutions.

2014

Abstract The association between attention-deficit hyperactivity disorder (ADHD) and criminality has been increasingly recognized as an important societal concern. Studies conducted in different settings have revealed high rates of ADHD among adolescent offenders. The risk for criminal behavior among individuals with ADHD is increased when there is psychiatric comorbidity, particularly conduct disorder and substance use disorder. In the present report, it is aimed to systematically review the literature on the epidemiological, neurobiological, and other risk factors contributing to this association, as well as the key aspects of the assessment, diagnosis, and treatment of ADHD among offende…

Conduct Disordermedicine.medical_specialtyAdolescentSubstance-Related DisordersPopulationTrastorns de l'atencióPsycINFORisk FactorsEpidemiologymental disordersmedicineAttention deficit hyperactivity disorderHumansPsiquiatriaeducationPsychiatryImprisonmentChildSerotonin Plasma Membrane Transport Proteinseducation.field_of_studyDopamine Plasma Membrane Transport ProteinsReceptors Dopamine D4Public Health Environmental and Occupational HealthCriminalsmedicine.diseaseSubstance abuseConduct disorderAttention Deficit Disorder with HyperactivityPediatrics Perinatology and Child HealthJuvenile DelinquencyPsychologyPsychosocial
researchProduct

A functional variant of the serotonin transporter gene (SLC6A4) moderates impulsive choice in attention-deficit/hyperactivity disorder boys and sibli…

2011

Item does not contain fulltext BACKGROUND: Impulsive drive for immediate reward (IDIR) and delay aversion are dissociable elements of the preference for immediate over delayed rewards seen in attention-deficit/hyperactivity disorder (ADHD). We hypothesized that IDIR would be associated with dopamine regulating genes and delay aversion would be associated with serotonin-regulating genes. METHODS: Impulsive drive for immediate reward and delay aversion were measured in 459 male children and adolescents (328 ADHD and 131 unaffected siblings) with a laboratory choice task. The sample was genotyped for the 5HTT (SLC6A4) promoter serotonin-transporter-linked polymorphic region polymorphism and a …

DEFICIT HYPERACTIVITY DISORDERMedizinSocial Sciencesimpulsivity610 Medicine & healthCHILDRENSingle-nucleotide polymorphismGenomic disorders and inherited multi-system disorders Functional Neurogenomics [IGMD 3]attention-deficit/hyperactivity disorderImpulsivityCOMBINED-TYPE ADHDREACTION-TIME PERFORMANCEDevelopmental psychologyGenomic disorders and inherited multi-system disorders [IGMD 3]DOPAMINE03 medical and health sciences0302 clinical medicineDopaminemedicineAttention deficit hyperactivity disorderddc:610Medizinische Fakultät » Universitätsklinikum Essen » LVR-Klinikum Essen » Klinik für Psychiatrie Psychosomatik und Psychotherapie des Kindes- und JugendaltersAlleleBiological PsychiatrySerotonin transporter030304 developmental biologyDopamine transporterGeneticsMental Health [NCEBP 9]0303 health sciencesDELAY AVERSIONbiologyTRYPTOPHAN DEPLETIONASSOCIATION10058 Department of Child and Adolescent Psychiatrymedicine.diseasePOLYMORPHISM5-HTTLPR (SLC6A4)5-HTTLPRbiology.proteinCRITERION VALIDITYmedicine.symptomDAT1 (SLC6A3)Psychology2803 Biological PsychiatryFunctional Neurogenomics [DCN 2]030217 neurology & neurosurgerymedicine.drugBiological Psychiatry
researchProduct

Importancia farmacológica y clínica de los receptores serotoninérgicos del tracto gastrointestinal

2001

Diarrheamedicine.medical_specialtyHepatologybusiness.industryInternal medicineGastroenterologymedicineVomitingmedicine.symptomSerotonin AntagonistsbusinessGastroenterologyGastroenterología y Hepatología
researchProduct

Biogenic amine levels, reproduction and social dominance in the queenless ant Streblognathus peetersi

2006

Social harmony often relies on ritualized dominance interactions between society members, particularly in queenless ant societies, where colony members do not have developmentally predetermined castes but have to fight for their status in the reproductive and work hierarchy. In this behavioural plasticity, their social organisation resembles more that of vertebrates than that of the "classic" social insects. The present study investigates the neurochemistry of the queenless ant species, Streblognathus peetersi, to better understand the neural basis of the high behavioural plasticity observed in queenless ants. We report measurements of brain biogenic amines [octopamine, dopamine, serotonin]…

Dominance-SubordinationMale0106 biological sciencesBiogenic AminesSerotonin[SDV.OT]Life Sciences [q-bio]/Other [q-bio.OT]DopamineReproduction (economics)HymenopteraBiology010603 evolutionary biology01 natural sciences03 medical and health sciencesHoney Bees0302 clinical medicineBiogenic amineAnimals[ SDV.OT ] Life Sciences [q-bio]/Other [q-bio.OT][SDV.BDD]Life Sciences [q-bio]/Development BiologyOctopamineEcology Evolution Behavior and Systematicschemistry.chemical_classification[SDV.OT] Life Sciences [q-bio]/Other [q-bio.OT]EcologyBrain[SDV.BDLR]Life Sciences [q-bio]/Reproductive BiologyGeneral Medicinebiology.organism_classificationHymenopteraEusocialityANTDominance (ethology)chemistryEvolutionary biologyFemaleStreblognathus peetersi030217 neurology & neurosurgery
researchProduct

Rewarding effects of 3,4-methylenedioxymethamphetamine (“Ecstasy”) in dominant and subordinate OF-1 mice in the place preference conditioning paradigm

2006

We tested the ability of 3,4-methylenedioxymethamphetamine (MDMA) to induce conditioned place preference (CPP) in dominant and subordinate OF-1 mice subjected to cohabitation and repeated sessions of agonistic confrontation, as well as in non-confronted mice. We selected doses of MDMA (2, 6, 10 mg/kg) previously reported to induce CPP in mice and we measured expression of c-Fos evoked by the treatments in non-confronted mice. MDMA induced c-Fos protein in several corticolimbic regions involved in drug-induced reward. Mice were exposed to brief sessions of agonistic confrontation on 5 consecutive days. Determinations of circulating hormones and drug conditioning tests were carried out on com…

Dominance-SubordinationMalemedicine.medical_specialtyN-Methyl-34-methylenedioxyamphetamineEcstasyGene ExpressionSocial EnvironmentMicechemistry.chemical_compoundSerotonin AgentsRewardCorticosteroneInternal medicinemedicineAnimalsTestosteroneBiological PsychiatryTestosteronePharmacologySocial stressGenes fosMDMAImmunohistochemistryConditioned place preferenceEndocrinologychemistryConditioning OperantCorticosteronePsychologyAgonistic BehaviorStress Psychologicalpsychological phenomena and processesGlucocorticoidmedicine.drugHormoneProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct